Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 8

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 8
---
 of non -redeemingshareholders who hold the securities until the consummation of the de -SPACtransaction. See the section entitled “ Proposal 1 — The Business Combination Proposal — Interests of Certain Persons in the Business Combination and Conflicts of Interest”. Conflicts of interest in connection with the Business Combination: There may be actual or potential material conflicts of interest between or among (i) the Sponsor and its affiliates, the NorthView Initial Stockholders, NorthView’s officers or directors, NorthView’s promotors, Profusa’s officers or directors, and (ii) the unaffiliated security holders of NorthView. In addition, I -Bankersand Dawson James, NorthView’s advisors and the managing underwriters of NorthView’s IPO, have a financial interest that may conflict with your interests. Such conflicts of interest may include a material conflict of interest arising in determining whether to proceed with the Business Combination and a material conflict of interest arising from the interests that the Sponsor and affiliates have in the Business Combination. For instance, due to its ownership of founders shares that will become worthless if an initial business combination is not completed, the Sponsor will benefit from the completion of the Business Combination and may be incentivized to complete a business combination that is less favorable to shareholders rather than liquidating. Likewise, the Sponsor and its affiliates can earn a positive rate of return on their investments, even if the NorthView Public Holders experience a negative rate of return on their investments in NorthView and New Profusa. For a further discussion of these considerations, see the section entitled “ Proposal 1 — The Business Combination Proposal — Interests of Certain Persons in the Business Combination and Conflicts of Interest”. The consolidated financial statements of NorthView and Profusa appearing in this proxy statement/prospectus have been audited by Marcum LLP, independent registered public accounting firm. The headquarters of Marcum LLP are located at 730 3rd Ave 11th Floor, New York, NY 10017. NorthView’s securities were delisted from the Nasdaq Capital Market on December 27, 2024, due to our failure to complete an initial business combination within the timeframe required under Nasdaq Rule IM -5101-2 .NorthView’s shares of Common Stock, public warrants and rights are currently quoted on OTC Pink under the symbols “NVAC,” “NVACW,” and “NVACR” respectively. Upon consummation of the Business Combination, New Profusa’s shares of Common Stock and public warrants will be listed